275 related articles for article (PubMed ID: 26101128)
1. Effects of new biomimetic regenerating agents on corneal wound healing in an experimental model of post-surgical corneal ulcers.
Alcalde I; Íñigo-Portugués A; Carreño N; Riestra AC; Merayo-Lloves JM
Arch Soc Esp Oftalmol; 2015 Oct; 90(10):467-74. PubMed ID: 26101128
[TBL] [Abstract][Full Text] [Related]
2. RGTA in corneal wound healing after transepithelial laser ablation in a rabbit model: a randomized, blinded, placebo-controlled study.
Xeroudaki M; Peebo B; Germundsson J; Fagerholm P; Lagali N
Acta Ophthalmol; 2016 Nov; 94(7):685-691. PubMed ID: 27227481
[TBL] [Abstract][Full Text] [Related]
3. Impact of topical anti-fibrotics on corneal nerve regeneration in vivo.
Hindman HB; DeMagistris M; Callan C; McDaniel T; Bubel T; Huxlin KR
Exp Eye Res; 2019 Apr; 181():49-60. PubMed ID: 30660507
[TBL] [Abstract][Full Text] [Related]
4. Plasma rich in growth factors (PRGF-Endoret) stimulates corneal wound healing and reduces haze formation after PRK surgery.
Anitua E; Muruzabal F; Alcalde I; Merayo-Lloves J; Orive G
Exp Eye Res; 2013 Oct; 115():153-61. PubMed ID: 23872360
[TBL] [Abstract][Full Text] [Related]
5. [Confocal microscopy of the corneal after photorefractive keratectomy with the excimer laser].
Böhnke M; Schipper I; Thaer A
Klin Monbl Augenheilkd; 1997 Sep; 211(3):159-67. PubMed ID: 9445896
[TBL] [Abstract][Full Text] [Related]
6. Matrix-Based Regenerating Agent for Corneal Wound Healing After Collagen Cross-Linking.
Hovakimyan M; Stachs O; Céline O; Guthoff RF
Cornea; 2016 Dec; 35(12):1638-1643. PubMed ID: 27755188
[TBL] [Abstract][Full Text] [Related]
7. Neutralizing antibody to TGFbeta modulates stromal fibrosis but not regression of photoablative effect following PRK.
Møller-Pedersen T; Cavanagh HD; Petroll WM; Jester JV
Curr Eye Res; 1998 Jul; 17(7):736-47. PubMed ID: 9678420
[TBL] [Abstract][Full Text] [Related]
8. Neurotrophic Keratopathy: Therapeutic Approach Using a Novel Matrix Regenerating Agent.
Guerra M; Marques S; Gil JQ; Campos J; Ramos P; Rosa AM; Quadrado MJ; Murta JN
J Ocul Pharmacol Ther; 2017 Nov; 33(9):662-669. PubMed ID: 28910175
[TBL] [Abstract][Full Text] [Related]
9. Healing of resistant corneal neurotrophic ulcers using a matrix regenerating agent.
Cochener B; Zagnoli C; Hugny-Larroque C; Derrien S
J Fr Ophtalmol; 2019 Feb; 42(2):159-165. PubMed ID: 30573293
[TBL] [Abstract][Full Text] [Related]
10. Confocal microscopic characterization of wound repair after photorefractive keratectomy.
Møller-Pedersen T; Li HF; Petroll WM; Cavanagh HD; Jester JV
Invest Ophthalmol Vis Sci; 1998 Mar; 39(3):487-501. PubMed ID: 9501858
[TBL] [Abstract][Full Text] [Related]
11. Matrix Regeneration Therapy: A Case Series of Corneal Neurotrophic Ulcers.
Arvola RP; Robciuc A; Holopainen JM
Cornea; 2016 Apr; 35(4):451-5. PubMed ID: 26845313
[TBL] [Abstract][Full Text] [Related]
12. The Impact of Photorefractive Keratectomy and Mitomycin C on Corneal Nerves and Their Regeneration.
Medeiros CS; Marino GK; Lassance L; Thangavadivel S; Santhiago MR; Wilson SE
J Refract Surg; 2018 Dec; 34(12):790-798. PubMed ID: 30540361
[TBL] [Abstract][Full Text] [Related]
13. RGTA-based matrix therapy in severe experimental corneal lesions: safety and efficacy studies.
Brignole-Baudouin F; Warnet JM; Barritault D; Baudouin C
J Fr Ophtalmol; 2013 Nov; 36(9):740-7. PubMed ID: 23958066
[TBL] [Abstract][Full Text] [Related]
14. The healing of alkali-injured cornea is stimulated by a novel matrix regenerating agent (RGTA, CACICOL20): a biopolymer mimicking heparan sulfates reducing proteolytic, oxidative and nitrosative damage.
Cejkova J; Olmiere C; Cejka C; Trosan P; Holan V
Histol Histopathol; 2014 Apr; 29(4):457-78. PubMed ID: 24105332
[TBL] [Abstract][Full Text] [Related]
15. Effect of cytochrome c peroxidase on the corneal epithelial healing process after excimer laser photo-ablation in transgenic mice.
Scorolli L; Meduri A; Morara M; Scalinci SZ; Meduri RA
Eur Surg Res; 2007; 39(2):82-7. PubMed ID: 17283431
[TBL] [Abstract][Full Text] [Related]
16. Measurement of mRNAs for TGFss and extracellular matrix proteins in corneas of rats after PRK.
Chen C; Michelini-Norris B; Stevens S; Rowsey J; Ren X; Goldstein M; Schultz G
Invest Ophthalmol Vis Sci; 2000 Dec; 41(13):4108-16. PubMed ID: 11095603
[TBL] [Abstract][Full Text] [Related]
17. [Pilot study of a new matrix therapy agent (RGTA OTR4120) in treatment-resistant corneal ulcers and corneal dystrophy].
Chebbi CK; Kichenin K; Amar N; Nourry H; Warnet JM; Barritault D; Baudouin C
J Fr Ophtalmol; 2008 May; 31(5):465-71. PubMed ID: 18641578
[TBL] [Abstract][Full Text] [Related]
18. Topical treatment with a new matrix therapy agent (RGTA) for the treatment of corneal neurotrophic ulcers.
Aifa A; Gueudry J; Portmann A; Delcampe A; Muraine M
Invest Ophthalmol Vis Sci; 2012 Dec; 53(13):8181-5. PubMed ID: 23150626
[TBL] [Abstract][Full Text] [Related]
19. Mitomycin C alters corneal stromal wound healing and corneal haze in rabbits after argon-fluoride excimer laser photorefractive keratectomy.
Lai YH; Wang HZ; Lin CP; Chang SJ
J Ocul Pharmacol Ther; 2004 Apr; 20(2):129-38. PubMed ID: 15117569
[TBL] [Abstract][Full Text] [Related]
20. Experimental use of tetrodotoxin for corneal pain after excimer laser keratectomy.
Schwartz DM; Duncan KG; Duncan JL
Cornea; 1998 Mar; 17(2):196-9. PubMed ID: 9520198
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
